Cohen Jonathan D, Shapiro Maury, Grozovski Elad, Lev Shaul, Fisher Heran, Singer Pierre
Department of General Intensive Care, Rabin Medical Center, Campus Beilinson, Petah Tikva, and the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Crit Care Med. 2006 Mar;34(3):682-6. doi: 10.1097/01.CCM.0000201888.32663.6A.
We hypothesized that the additional use of automatic tube compensation (ATC) during a spontaneous breathing trial with continuous positive airway pressure (CPAP), by minimizing respiratory work, would result in more patients undergoing successful extubation.
Prospective, randomized, controlled study.
A ten-bed, general intensive care department at a tertiary-care hospital.
Adult patients (n=99) who had undergone mechanical ventilation for >24 hrs and met defined criteria for a weaning trial.
Patients were randomized to undergo a 1-hr spontaneous breathing trial with either ATC with CPAP (ATC group, n=51) or CPAP alone (CPAP group, n=48). ATC was provided by commercially available mechanical ventilators. Patients tolerating the spontaneous breathing trial underwent immediate extubation. The primary outcome measure was successful extubation, defined as the ability to maintain spontaneous breathing for 48 hrs after discontinuation of mechanical ventilation and extubation.
There were no significant differences in demographic, respiratory, or hemodynamic characteristics between the two groups at the start of the spontaneous breathing trial. There was a trend for more patients in the ATC group to tolerate the breathing trial and undergo extubation (96% vs. 85%; p=.08). The rate of reintubation was 14% in the ATC group and 24% in the CPAP group (p=.28). Significantly more patients in the ATC group thus met the criteria for successful extubation (82% vs. 65%; p=0.04).
This is the largest single-center study to date assessing the use of commercially available ATC and suggests that this might be a useful mode for performing a spontaneous breathing trial preceding extubation in a general intensive care population.
我们假设在持续气道正压通气(CPAP)的自主呼吸试验期间额外使用自动管道补偿(ATC),通过最小化呼吸功,将使更多患者成功拔管。
前瞻性、随机、对照研究。
一家三级医院的拥有十张床位的综合重症监护病房。
接受机械通气超过24小时且符合撤机试验既定标准的成年患者(n = 99)。
患者被随机分配接受1小时的自主呼吸试验,试验方式为使用ATC联合CPAP(ATC组,n = 51)或仅使用CPAP(CPAP组,n = 48)。ATC由市售机械通气机提供。耐受自主呼吸试验的患者立即进行拔管。主要结局指标为成功拔管,定义为机械通气和拔管停止后能够维持自主呼吸48小时。
在自主呼吸试验开始时,两组患者在人口统计学、呼吸或血流动力学特征方面无显著差异。ATC组有更多患者倾向于耐受呼吸试验并接受拔管(96%对85%;p = 0.08)。ATC组的再次插管率为14%,CPAP组为24%(p = 0.28)。因此,ATC组中显著更多的患者符合成功拔管标准(82%对65%;p = 0.04)。
这是迄今为止评估市售ATC使用情况的最大规模单中心研究,表明这可能是在综合重症监护人群中进行拔管前自主呼吸试验的一种有用模式。